Summit Therapeutics Inc (SMMT)

Etorro trading 970x250
Summit Therapeutics Inc (SMMT) Logo

About Summit Therapeutics Inc

Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States, Latin America, and Europe. It conducts clinical programs focusing on the Clostridium difficile infection (CDI). The company’s lead product candidate is ridinilazole, an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. It also develops DDS-01 series to treat infection caused by the bacteria Neisseria gonorrhoeae through Discuva platform; and DDS-04 series to treat Enterobacteriaceae. Summit Therapeutics Inc. was founded in 2003 and is based in Cambridge, Massachusetts. Address: One Broadway, Cambridge, MA, United States, 02142

Summit Therapeutics Inc News and around…

Latest news about Summit Therapeutics Inc (SMMT) common stock and company :

Summit Therapeutics Inc Reports Financial Results and Operational Progress for the Third Quarter and Nine Months Ended September 30, 2021
15 Nov, 2021 Yahoo! Finance

Cambridge, Massachusetts, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today reports its financial results and provides an update on its operational progress for the third quarter and nine months ended September 30, 2021. Note: A glossary of terms is included at the end of this document in order to allow for the ease of understanding of terms or concepts used throughout this release. Financial Highlights Aggregate cash, accounts rec

Acurx Pharmaceuticals’ Drug Candidate Ibezapolstat Continues To Score Clinical Wins In Treating C. Difficile (NASDAQ: ACXP)
10 Nov, 2021 FinancialContent
Summit Therapeutics Bolsters Its Board of Directors with Seasoned Regulatory & Clinical Research Executive Dr. Urte Gayko
03 Nov, 2021 Yahoo! Finance

Cambridge, Massachusetts, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) today announced that Dr. Urte Gayko, PhD, has been appointed to our Board of Directors, effective immediately. Dr. Gayko is currently the Senior Vice President of Drug Development & Regulatory Affairs at Nektar Therapeutics. Dr. Gayko previously served as the Global Head of Regulatory Affairs and Pharmacovigilance at Pharmacyclics, Inc., and has over 20 years of experience in areas encompassing re

AcurX Pharmaceuticals’ C. Difficile Drug Candidate Could Fetch $800 Million On A Peer Comparison Basis (NASDAQ: ACXP)
20 Oct, 2021 FinancialContent
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Summit Therapeutics Inc. - SMMT
13 Oct, 2021 Yahoo! Finance

NEW YORK, NY / ACCESSWIRE / October 13, 2021 / Pomerantz LLP is investigating claims on behalf of investors of Summit Therapeutics Inc. ("Summit" or the "Company") (NASDAQ:SMMT).

Summit Therapeutics Appoints Prominent Biotech Attorney and Advisor Kenneth A. Clark to Its Board of Directors
08 Oct, 2021 Yahoo! Finance

Cambridge, MA, Oct. 08, 2021 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) today announced that Kenneth A. Clark, JD, has been appointed to our Board of Directors, effective immediately. Mr. Clark is currently a partner at Wilson Sonsini Goodrich & Rosati (WSGR) based out of the firm’s Palo Alto, CA, office. At WSGR, Ken advises biotech companies in strategic partnerships, mergers and acquisitions, and financing transactions, in addition to a range of other matters. He has previous

(SMMT) Alert: Did You Lose Money on Your Summit Therapeutics Investment? Contact Johnson Fistel Regarding Investigation
02 Oct, 2021 Yahoo! Finance

Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of the federal securities laws by Summit Therapeutics Inc. ("Summit" or the "Company") (NASDAQ: SMMT).

Summit Therapeutics Presents Further Breakthrough Insights Surrounding the Novel Mechanism of Action for its Investigational Drug Ridinilazole During IDWeek 2021
30 Sep, 2021 FinancialContent
Antimicrobials Working Group Highlights Member Company Participation at IDWeek 2021
30 Sep, 2021 Yahoo! Finance

The Antimicrobials Working Group (AWG), a coalition of companies with the mission to combat drug resistant infections and spur life-saving innovations, today announced that 10 of its member companies will present data from their clinical and research programs at IDWeek 2021 taking place virtually from September 29-October 3, 2021. AWG members are presenting a total of 23 poster presentations and 3 oral abstract presentations.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Summit Therapeutics Inc. - SMMT
24 Sep, 2021 FinancialContent
50 Biggest Movers From Yesterday
23 Sep, 2021 FinancialContent

Gainers Marin Software Incorporated (NASDAQ: MRIN) shares jumped 61.9% to close at $9.21 on Wednesday following an announcement ...

12 Health Care Stocks Moving In Wednesday's After-Market Session
22 Sep, 2021 FinancialContent

Gainers Regencell Bioscience (NASDAQ:RGC) shares rose 21.54% to $25.1 during Wednesday's after-market session. ...

Mid-Afternoon Market Update: Dow Surges Over 400 Points; Stitch Fix Shares Spike Higher
22 Sep, 2021 FinancialContent

Toward the end of trading Wednesday, the Dow traded up 1.28% to 34,353.01 while the NASDAQ rose 1.07% to 14,904.89. The S&P also ...

Mid-Day Market Update: Nasdaq Jumps 100 Points; InnovAge Shares Plummet
22 Sep, 2021 Yahoo! Finance

Midway through trading Wednesday, the Dow traded up 1.01% to 34,261.10 while the NASDAQ rose 0.70% to 14,850.10. The S&P also rose, gaining 0.83% to 4,390.54. The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 42,413,620 cases with around 678,500 deaths. India confirmed a total of at least 33,531,490 cases and 445,760 deaths, while Brazil reported over 21,247,090 COVID-19 cases with 591,440 deaths. In total, there were at least 229,573,930 cases of

32 Stocks Moving In Wednesday's Mid-Day Session
22 Sep, 2021 FinancialContent

Gainers Marin Software Incorporated (NASDAQ: MRIN) shares climbed 53.1% to $8.71 following an announcement from management that ...

RSI Alert: Summit Therapeutics (SMMT) Now Oversold
22 Sep, 2021 FinancialContent

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100..

Wednesday Sector Laggards: Diagnostics, Biotechnology Stocks
22 Sep, 2021 FinancialContent

In trading on Wednesday, diagnostics shares were relative laggards, up on the day by about 0.1%. Helping drag down the group were shares of Greenbrook, off about 18.4% and shares of Signify Health down about 5.6% on the day.

Mid-Morning Market Update: Markets Open Higher; General Mills Reports Upbeat Q1 Results
22 Sep, 2021 FinancialContent

Following the market opening Wednesday, the Dow traded up 1.01% to 34,262.50 while the NASDAQ rose 0.63% to 14,839.63. The S&P also ...

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
22 Sep, 2021 FinancialContent

Gainers Aethlon Medical (NASDAQ:AEMD) shares rose 33.15% to $5.06 during Wednesday's pre-market session. The market ...

The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs
22 Sep, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

FDA Not In Favor Of Summit Therapeutics' Endpoint Change To Pivotal Infection Trials
22 Sep, 2021 FinancialContent

Summit Therapeutics Inc(NASDAQ: SMMT) announced that the FDA disagrees with its proposed change to the primary endpoint in ...

SMMT Makes Notable Cross Below Critical Moving Average
08 Sep, 2021 FinancialContent

In trading on Wednesday, shares of Summit Therapeutics Inc (SMMT) crossed below their 200 day moving average of $6.56, changing hands as low as $6.45 per share. Summit Therapeutics Inc shares are currently trading off about 2.8% on the day..

Summit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter and Six Months Ended June 30, 2021
11 Aug, 2021 FinancialContent
Summit Therapeutics Provides Update on Ri-CoDIFy Trials
11 Aug, 2021 FinancialContent
Acurx Pharmaceuticals Joins the Antimicrobials Working Group
05 Aug, 2021 Yahoo! Finance

The Antimicrobials Working Group (AWG) announced today the addition of Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) (Acurx) to its coalition of companies with the mission to combat drug resistant infections and spur life-saving innovations. This new addition brings AWG's membership to 13 antimicrobial drug companies.

Summit Therapeutics Presents Breakthrough Research Data from Phase II Studies, including Evidence Validating Microbiome Preservation, for its Investigational Drug Ridinilazole
12 Jul, 2021 FinancialContent

Data Additionally include Potential Benefit for the Control of Antimicrobial Resistance and a Novel Mechanism of Action

Summit Therapeutics to Present Breakthrough Research Updates at the 31st Annual ECCMID Conference, including a Top-Rated ePoster
01 Jul, 2021 FinancialContent
Crestone Joins Antimicrobials Working Group
08 Jun, 2021 Yahoo! Finance

The Antimicrobials Working Group (AWG) announced today the addition of Crestone, Inc. (Crestone) to its coalition of companies with the mission to combat drug resistant infections and spur life-saving innovations. This new addition brings AWG's membership to 12 antimicrobial drug companies.

Summit Therapeutics set to join Russell 3000® Index
08 Jun, 2021 FinancialContent
Summit Therapeutics’ Upcoming Annual Shareholders’ Meeting
03 Jun, 2021 FinancialContent

Summit Therapeutics Inc (SMMT) is a NASDAQ Common Stock listed in , ,

970x250